Novo Nordisk CEO to step down as competition weighs on Wegovy maker’s share price

Novo Nordisk CEO to step down as competition weighs on Wegovy maker’s share price


Novo Nordisk CEO Lars Jorgensen testifies before a Senate Health, Education, Labor, and Pensions Committee hearing on U.S. prices for the weight loss drugs Ozempic and Wegovy, on Capitol Hill in Washington, U.S., September 24, 2024. 

Piroschka Van De Wouw | Reuters

Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down, the Wegovy-maker said Friday, citing recent market challenges.

The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post “for a period to support a smooth transition to new leadership.” It added that the search for a replacement was ongoing and an announcement would be made in due course.

Novo Nordisk shares were last trading 3% lower. Meanwhile, shares of rival obesity drug maker Eli Lilly were up 1.6% in premarket trading.

The decision comes as Novo Nordisk’s share price has taken a battering over the past year amid increased competition in the ballooning obesity drug market and disappointing trial results for its next-generation treatments.

The company’s share price is currently down by more than 50% since the middle of 2024.

“Novo Nordisk’s strategy remains unchanged, and the Board is confident in the company’s current business plans and its ability to execute on the plans,” Chairman Helge Lund said in a statement.

“The changes are, however, made in light of the recent market challenges Novo Nordisk has been facing, and the development of the company’s share price since mid-2024,” the company said in a statement.

In connection with the change, the company said that Novo Nordisk Foundation chair Lars Rebien Sørensen will join Novo Nordisk’s board, initially as an observer.

This is a breaking news story, please check back for updates.



Source

Top Wall Street analysts recommend these dividend stocks for regular income
World

Top Wall Street analysts recommend these dividend stocks for regular income

A sign is posted on the exterior of a Verizon store on September 30, 2024 in Daly City, California.  Justin Sullivan | Getty Images News | Getty Images As the stock market focuses on major earnings and negotiations on the tariff front, investors seeking a regular income stream continue to look for attractive dividend stocks […]

Read More
Global week ahead: Crunch time for trade talks as Trump’s deadline nears
World

Global week ahead: Crunch time for trade talks as Trump’s deadline nears

U.S. President Donald Trump speaks to the media during a tour of the Federal Reserve Board building, which is currently undergoing renovations, in Washington, D.C., U.S., July 24, 2025. Kent Nishimura | Reuters I think most would agree that the news cycle has been relentless for most of 2025, but certain stories do seem a […]

Read More
Are 2 to 3 cups of coffee a day too much? It’s complicated, experts say: ‘It’s different for each person’
World

Are 2 to 3 cups of coffee a day too much? It’s complicated, experts say: ‘It’s different for each person’

Two-thirds of Americans drink coffee every single day, according to data collected by the National Coffee Association in 2022, and the debate about how much is too much and whether or not any amount of caffeine is safe persists. But recent research shows that the answer is more complicated than you’d think. A Harvard study, that followed […]

Read More